Clinical trials
Phase 1/2 Lupus Erythematosus, Systemic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 8 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
| Active, not recruiting | 2 |
| Completed | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essen Biotech | 2 |
| Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 1 |
| Beijing Biotech | 1 |
| Beijing GoBroad Hospital | 1 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| Daiichi Sankyo | 1 |
| Excyte Biopharma Ltd | 1 |
| Gracell Biotechnologies (Shanghai) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 19 |
| Lupus Nephritis | 4 |
| Autoimmune Diseases | 3 |
| Sjogren's Syndrome | 2 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Granulomatosis with Polyangiitis | 1 |
| Microscopic Polyangiitis | 1 |
| Myositis | 1 |
| Scleroderma, Systemic | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.